Skip to content
Peptide research

Chemerin-9

Also known as Chem-9
Category
Weight Management & Metabolic
Regulatory status
Not FDA-approved

What it is

A 9-amino-acid fragment of the adipokine chemerin, marketed for immune modulation, fat metabolism, and antimicrobial skin effects via the ChemR23 receptor. The case rests on mechanism and cell studies only, with no controlled human trials, and even those effects are rated low confidence or speculative. There is no human safety data, and a pro-inflammatory effect at high doses is unresolved. Not an approved drug, sold as unregulated research-grade material.

Read Full record

Studied uses & evidence

Studied uses(3)

  • Chemoattractant for immune cells (dendritic cells, macrophages, NK cells) via CMKLR1

    Low

    Documented mainly for full-length chemerin in vitro and in mice, not this fragment in humans.

  • Full agonist activity at CMKLR1 — minimal functional fragment for receptor activation

    Low

    Receptor binding and activation are well characterized structurally, with no demonstrated human benefit.

  • Regulation of adipogenesis and energy metabolism through CMKLR1 in adipose tissue

    Low

    Animal and cell studies show metabolic effects via this receptor; human data are lacking.

Evidence limits

Evidence Level
Early Research (Preclinical Only, No Human Trials)

Chemerin-9 is purely a research peptide with no human clinical trials. All evidence comes from in-vitro cell culture, structural biology (cryo-EM), and animal models. The cited antimicrobial skin-infection findings concern p4, not chemerin-9. Metabolic associations come from observational human studies measuring circulating chemerin levels, not from chemerin-9 administration. The structural and mechanistic understanding is strong, but therapeutic translation is in very early stages.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(3)

Risks = level of concern: High · Moderate · Low · Theoretical

  • No human safety data available

    High
  • Potential pro-inflammatory effects at high concentrations

    Moderate
  • Metabolic effects uncertain

    Moderate
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.